ChiCTR1900026244
尚未开始
/
/
/
2019-09-28
/
/
乳腺癌
乳腺癌生存者自我管理應用程式的隨機對照試驗
Breast Cancer App protocol: a randomized controlled trial to evaluate a self-management app for breast cancer survivors
1) to examine whether there is the difference in the health literacy, problem solving skills, readiness of change, self-efficacy, self-management skill, and health-related quality of life between the intervention group and the control group; 2) to examine the usability of this self-management app versus a general health app.
随机平行对照
探索性研究/预试验
SPSS (IBM SPSS Statistics Version 25) will be used to generate the random sequence for group allocation.
Not addressed
Departmental research fund
/
244
/
2020-01-01
2021-06-30
/
1) female; 2) breast cancer survivors; 3) Cancer stages I to III; 4) completion of primary treatment within one year or longer; 5) aged 18 to 65 years; 6) acceptable literacy level (e.g. able to read, and write Chinese); 7) agree for checking of usage log of mobile app; 8) able to provide informed consent.；
登录查看1) BCS diagnosed with severe mental illnesses; 2) Diagnosis of another cancer type rather than breast cancer; 3) has already participated in other clinical trial; 4) has been used other self-management app to manage the breast cancer.；
登录查看香港理工大學康復科學系
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
